✦ LIBER ✦

Efficacy of Veliparib (ABT-888) Plus Temozolomide Versus Temozolomide Alone: a Randomized, Double-blind, Placebo-controlled Trial in Patients with Metastatic Melanoma

✍ Scribed by M. Middleton; P. Friedlander; O. Hamid; A. Daud; R. Plummer; R. Schuster; J. Qian; Y. Luo; V. Giranda; G. McArthur

Book ID: 117660611
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(11)70112-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

✍ Michael C. Rowbotham; W. Rachel Duan; James Thomas; Wolfram Nothaft; Misha-Miros 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

LETTER: A Randomized, Double-Blind, Plac

LETTER: A Randomized, Double-Blind, Placebo-Controlled Trial of Interferon-α and Amantadine Versus Interferon-α Alone in the Treatment of Patients with Chronic Hepatitis C

✍ Jawad Ahmad; Hugo Vargas; Vijayan Balan; Jorge Rakela; A. Obaid Shakil 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 36 KB

Phase II, double-blind, randomized trial

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

✍ Mark Clemons; Anil A. Joy; Radhi Abdulnabi; Mauricio Kotliar; Jodi Lynch; Johan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 317 KB

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m

Evaluation of the efficacy and tolerabil

Evaluation of the efficacy and tolerability of two different dosages of fenticonazole vaginal ovules (600 mg and 1000 mg) in patients with vaginal trichomoniasis: A controlled, double-blind, randomized clinical trial versus placebo

✍ F. Gorlero; S. Macchiavello; L. Pellegatta; M.L. Airoldi; B. Gaffuri; L. Pulici; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 529 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up noninferiority trial

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB